Brilinta Added to Recommended Agents for MI (CME/CE)
12:00 EDT 16 Jul 2012 | MedPageToday
(MedPage Today) -- Two medical societies have updated their joint guideline for the management of non-ST-segment MI and unstable angina to include the most recently approved anti-platelet agent, ticagrelor (Brilinta).
Original Article: Brilinta Added to Recommended Agents for MI (CME/CE)
More From BioPortfolio on "Brilinta Added to Recommended Agents for MI (CME/CE)"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
